MedTrace Logo

Enhancing the Outcomes of a Behavioral Parent Training Intervention

NCT02704221 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2018-09-17

No results posted yet for this study

Summary

This study is a feasibility trial, testing the hypothesis that among sedentary mothers of behaviorally at-risk preschool-aged children, those who receive behavioral parent training (BPT) programs and concurrently increase their physical activity levels will demonstrate improved parenting and child behavior outcomes compared to those who receive BPT but remain sedentary.

Conditions

  • Disruptive Behavior Disorder
  • Parenting

Interventions

BEHAVIORAL

Fitbit activity tracker

Wear a Fitbit daily for 12 weeks and meet with a research assistant once per week to download data

BEHAVIORAL

Monetary rewards

Set weekly step-count goals based on the previous week's performance and receive monetary rewards for meeting the goals. The schedule of rewards increases as step-count goals increase.

BEHAVIORAL

BPT training sessions

Complete 12 BPT training sessions delivered by supervised clinical child psychology doctoral students, with each session lasting approximately 60 minutes. The BPT is based upon the existing, evidence-based Everyday Parenting intervention.

Sponsors & Collaborators

  • University of Vermont

    collaborator OTHER

  • Christina Studts

    lead OTHER

Principal Investigators

  • Christina Studts, PhD, LCSW · University of Kentucky

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-03-01
Primary Completion
2017-10-01
Completion
2018-09-13

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02704221 on ClinicalTrials.gov